Indo US Bio-Tech Ltd (INDOUS)
·Next Day Close·-1.67%·₹76.32
Key EventTrading window closes before Q2/H1 results release
The board reconstituted its Audit, Nomination and Remuneration, and Stakeholders Relationship committees following the appointment of Hemanshi Darsh Soni as an additional independent director after Mrs. Nehaben Patel's resignation. The changes took effect from 10 July 2026 to ensure compliance with SEBI and Companies Act requirements. The board meeting commenced at 3:00 PM and concluded at 3:30 PM.
Sign up to read summary